Data from Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and NeckJennifer L. Leddon, Trisha M. Wise‐Draper, Shuchi Gulati et al.|Unknown|2023Cited by 1
Supplementary Table from Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and NeckJennifer L. Leddon, Trisha M. Wise‐Draper, Shuchi Gulati et al.|Unknown|2023Cited by 0
Supplementary Table from Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and NeckJennifer L. Leddon, Trisha M. Wise‐Draper, Alice Tang et al.|Unknown|2023Cited by 0
Data from Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and NeckJennifer L. Leddon, Trisha M. Wise‐Draper, Muhammed Kashif Riaz et al.|Unknown|2023Cited by 0
Supplementary Table from Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and NeckJennifer L. Leddon, Trisha M. Wise‐Draper, Shuchi Gulati et al.|Unknown|2023Cited by 0